NetworkNewsBreaks

TuesdayJun 26, 2018 1:55 pm

NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Prepared to Cultivate Opportunity in Okanogan County, Washington

Marijuana Company of America Inc. (OTC: MCOA) has completed phase one construction of its Okanogan County, Washington greenhouse facilities in time for the 2018 planting season. An article discussing the venture reads: “The joint venture will lease the turnkey property to a third-party licensed tenant, thus acting solely as a landlord. The tenant will be able to take occupation of the property and begin cultivation once the inspection is approved. As a turnkey landlord, BV-MCOA aims to provide an ideal cultivation environment for its future tenants. The company anticipates completion of greenhouse facilities for its entire 30,000 square foot cultivation…

Continue Reading

TuesdayJun 26, 2018 11:48 am

NetworkNewsBreaks – Sharing Services, Inc. (SHRV) Subsidiary to Launch Product Line in Australia, New Zealand

Texas-based Sharing Services, Inc. (OTC: SHRV) this morning announced that its wholly owned subsidiary, Elevacity Global, LLC, intends to launch its product line in Australia and New Zealand in 2018. The company has started the first steps of the process in agreement with legal and compliance requirements and will expedite the process to rapidly fulfill consumer demand. "Sharing Services is pleased to see international demand for our products. We are diligently working to first launch our brand in countries demonstrating extreme interest, which at this time is Australia and New Zealand. The Elevacity Global Brand is distributed through our Elepreneur…

Continue Reading

TuesdayJun 26, 2018 11:18 am

NetworkNewsBreaks – EVIO, Inc.’s (EVIO) Berkeley, CA Lab Receives ISO 17025 Accreditation

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that its laboratory located in Berkeley, California, C3 Labs, LLC DBA EVIO Labs, has attained ISO 17025 accreditation from Perry Johnson Laboratory Accreditation, Inc. (“PJLA”). ISO 17025 accreditation is the highest recognized quality standard for calibration and testing laboratories, requiring personnel to have met specific academic and training credentials. The accreditation also requires the facility to operate under a quality management system and consistently produce precise and accurate tests for cannabinoids, pesticides, and contaminants. "EVIO is committed to upholding…

Continue Reading

TuesdayJun 26, 2018 10:57 am

NetworkNewsBreaks – Medical Cannabis Payment Solutions (REFG) Details Plans to Pursue Hemp Cultivation Program in Vermont

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) this morning announced that it is working on growing industrial hemp as part of Vermont’s industrial hemp program. Per the update, the company is currently evaluating multiple properties to commence growing and anticipates completing its first harvest in 2019. “While we are fully committed to our solution to the banking and financial transaction problems in the state sanctioned marijuana industry, we are pleased thus far with our diversification into CBD extraction,” Jeremy Roberts, CEO of REFG, stated in the news release. “With the recent approval of a CBD based medicine…

Continue Reading

TuesdayJun 26, 2018 10:40 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) to Present at the National Investment Banking Conference; Provides Company Update

SinglePoint, Inc. (OTCQB: SING) this morning announced that it will be presenting at the National Investment Banking Association Conference (“NIBA”) in New York. NIBA provides the company the opportunity to attract additional institutional coverage due to the improvements in the corporate structure. During the two-day conference, company management will be presenting and meeting with investors to increase visibility and build momentum for SinglePoint. The company believes that many milestones it has reached in the past six months, including its completed audits, up-listing to the OTCQB and Form 10 filing to become a fully reporting company, will help attract opportunities for…

Continue Reading

TuesdayJun 26, 2018 10:03 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Inks MOU with Vehicle Importer in Israel

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) this morning said that it has signed a non-binding memorandum of understanding (“MOU”) with a direct importer of several leading vehicle manufacturers to Israel. The MOU covers the terms of an agreement for the sale of Foresight’s advanced driver assistance system (“ADAS”), the Eyes-On™ system, for aftermarket configuration and integration into the importer's vehicles in Israel. Once a binding agreement is signed, a pilot project will begin, using a beta version of the Eyes-On™ system to integrate into a number of models from the importer’s fleet of vehicles. The binding agreement is expected…

Continue Reading

TuesdayJun 26, 2018 9:59 am

NetworkNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Appoints New Director of Operations

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Kyp Rowe as its new director of operations. Per the update, Rowe will play a key role in Choom’s strategic development moving forward, leading the company’s premium craft cannabis cultivation strategy in support of its retail roll-out for the Canadian recreational market. “Bringing Kyp onboard significantly strengthens our team as we continue to prepare for when the Canadian recreational cannabis market commences on October 17, 2018,” Chris Bogart, president and CEO of Choom, stated in the news release. “Kyp brings over 20…

Continue Reading

TuesdayJun 26, 2018 9:29 am

NetworkNewsBreaks – United American Corp. (UAMA) Enters Agreement for Major Expansion of Blockchain Mining Operations

Florida-based development and management company United American Corp. (“UnitedCorp”) (OTC: UAMA) this morning announced that its wholly owned subsidiary, Blockchain Data Centers Inc. (“BDC”), has entered into an expansion of its existing hosting service agreement with a Vancouver-based technology firm. Per the terms of the agreement, BDC will increase hosting of the client’s blockchain mining rigs from 1,000 to a total of 4,000. The company has already commenced construction to increase the capacity of its BlockchainDome Heat Station, and the first additional mining rigs are expected to be online in August. “We are very pleased with the now proven performance and efficiency of our…

Continue Reading

TuesdayJun 26, 2018 9:28 am

NetworkNewsBreaks – DeepMarkit Corp. (TSX-V: MKT) (OTCQB: MKTDF) Issues Business Development Update

DeepMarkit Corp. (TSX-V: MKT) (OTCQB: MKTDF) this morning issued an update regarding the company’s business development. Per the update, the company has achieved an average of 61% month-over-month growth in its merchant base since the March launch of its slide-out app Gamify for e-commerce websites. In response to the positive feedback, the company has developed many new features, including customization of all text fields providing multi-language capability and meeting GDPR (data protection) compliance to help confirm that customers in the EU can meet privacy requirements when collecting data and emails from consumers. In addition, the company is developing a gamified…

Continue Reading

MondayJun 25, 2018 2:46 pm

NetworkNewsBreaks – Processa Pharmaceuticals, Inc.’s (PCSA) PCS499 Receives Orphan Drug Designation from FDA to Treat Necrobiosis Lipoidica

Processa Pharmaceuticals (OTC: PCSA) recently announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to its leading clinical compound, PCS499, to treat Necrobiosis Lipoidica (“NL”). Presently, there is no FDA approved treatment for NL and no known biotech or pharma companies are currently developing a drug for NL. "We are very pleased that PCS499 has received Orphan Drug Designation from FDA for the treatment of NL. NL can have a major impact on the quality of life of patients and PCS499 will be the first treatment targeted to this condition. We plan to begin our…

Continue Reading